Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should ...

In December, MM+M surveyed readers on a number of topics, including the biggest buzzwords of 2025, work healthcare marketing leaders admire and the datapoints that define the industry. The ...

Pharma advertising operates in an environment where complexity is the norm. As privacy rules tighten and identity-based targeting erodes, marketers often find themselves relying on fading signals, ...

While 2025 was the year of disruption for Trump’s pharma policies, we expect 2026 to be the year of truth: will the US ...